LIGAND PHARMACEUTICALS INCORPORATED Proceeds from Derivative Instrument, Investing Activities
LIGAND PHARMACEUTICALS INCORPORATED (LGNYZ) reported Proceeds from Derivative Instrument, Investing Activities of $1.04 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Cash Flow › Investing Activities
us-gaap:ProceedsFromDerivativeInstrumentInvestingActivities · last filed 2026-08-07
- LIGAND PHARMACEUTICALS INCORPORATED proceeds from derivative instrument, investing activities for the quarter ending 2026-06-30 was $614.00K.
- LIGAND PHARMACEUTICALS INCORPORATED proceeds from derivative instrument, investing activities for the quarter ending 2026-03-31 was $431.00K.
- LIGAND PHARMACEUTICALS INCORPORATED proceeds from derivative instrument, investing activities for the quarter ending 2025-06-30 was $0.00.
- LIGAND PHARMACEUTICALS INCORPORATED proceeds from derivative instrument, investing activities for the quarter ending 2025-03-31 was $0.00.
- LIGAND PHARMACEUTICALS INCORPORATED proceeds from derivative instrument, investing activities for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
- LIGAND PHARMACEUTICALS INCORPORATED proceeds from derivative instrument, investing activities for fiscal 2024 was $7.12M.
- LIGAND PHARMACEUTICALS INCORPORATED proceeds from derivative instrument, investing activities for fiscal 2023 was $0.00.
- LIGAND PHARMACEUTICALS INCORPORATED proceeds from derivative instrument, investing activities for fiscal 2022 was $0.00.
| Period end | Proceeds from Derivative Instrument, Investing Activities 3 month | Proceeds from Derivative Instrument, Investing Activities 6 month | Proceeds from Derivative Instrument, Investing Activities 12 month |
|---|---|---|---|
| 2026-06-30 | $614.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $1.04M 10-Q · filed 2026-08-07 | |
| 2026-03-31 | $431.00K 10-Q · filed 2026-05-08 | ||
| 2025-12-31 | $0.00 10-K · filed 2026-02-27 | ||
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $0.00 10-Q · filed 2026-08-07 | |
| 2025-03-31 | $0.00 10-Q · filed 2026-05-08 | ||
| 2024-12-31 | $7.12M 10-K · filed 2026-02-27 | ||
| 2023-12-31 | $0.00 10-K · filed 2026-02-27 | ||
| 2022-12-31 | $0.00 10-K · filed 2025-02-28 |